Literature DB >> 22855039

Longer overall survival in a patient with advanced non-small cell lung cancer treated with Chinese medicine and chemotherapy.

Yan-Zhi Chen1, Zhan-Dong Li, Ning Zhou, Hong Sun, Ping-Ping Li.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22855039     DOI： 10.1007/s11655-012-1171-2

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN： 1672-0415            Impact factor:   1.978


× No keyword cloud information.
  5 in total

1.  Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer.

Authors:  G V Scagliotti; F De Marinis; M Rinaldi; L Crinò; C Gridelli; S Ricci; E Matano; C Boni; M Marangolo; G Failla; G Altavilla; V Adamo; A Ceribelli; M Clerici; F Di Costanzo; L Frontini; M Tonato
Journal:  J Clin Oncol       Date:  2002-11-01       Impact factor: 44.544

2.  [The randomized, multicenter, controlled clinic trail for treating advanced non-small cell lung cancer with combined traditional chinese medicine and vinorelbine (Navelbine, NVB) plus cisplatin (DDP) chemotherapy.].

Authors:  Yanzhi Chen; Lijun Di; Shulan Zhang; Maosen Chen; Hong Sun; Fei Gao; Ying Zhang; Pingping Li
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2008-06-20

3.  Effects of combined Chinese drugs and chemotherapy in treating advanced non-small cell lung cancer.

Authors:  Yan-zhi Chen; Zhan-dong Li; Fei Gao; Ying Zhang; Hong Sun; Ping-ping Li
Journal:  Chin J Integr Med       Date:  2010-01-18       Impact factor: 1.978

Review 4.  Updates in non-small cell lung cancer.

Authors:  Suzanne Walker
Journal:  Clin J Oncol Nurs       Date:  2008-08       Impact factor: 1.027

5.  Screening for epidermal growth factor receptor mutations in lung cancer.

Authors:  Rafael Rosell; Teresa Moran; Cristina Queralt; Rut Porta; Felipe Cardenal; Carlos Camps; Margarita Majem; Guillermo Lopez-Vivanco; Dolores Isla; Mariano Provencio; Amelia Insa; Bartomeu Massuti; Jose Luis Gonzalez-Larriba; Luis Paz-Ares; Isabel Bover; Rosario Garcia-Campelo; Miguel Angel Moreno; Silvia Catot; Christian Rolfo; Noemi Reguart; Ramon Palmero; José Miguel Sánchez; Roman Bastus; Clara Mayo; Jordi Bertran-Alamillo; Miguel Angel Molina; Jose Javier Sanchez; Miquel Taron
Journal:  N Engl J Med       Date:  2009-08-19       Impact factor: 91.245
  5 in total
  3 in total

Review 1.  Recent highlights of Chinese medicine for advanced lung cancer.

Authors:  Xi-Ran He; Shu-Yan Han; Ping-Ping Li
Journal:  Chin J Integr Med       Date:  2016-12-27       Impact factor: 1.978

2.  Clinical study on long-term overall survival of advanced non-small-cell lung cancer patients treated with Chinese medicine and Western medicine.

Authors:  Yan-zhi Chen; Xiao-bing Feng; Zhan-dong Li; Wen-xian Zheng; Hong Sun; Ping-ping Li
Journal:  Chin J Integr Med       Date:  2014-03-04       Impact factor: 1.978

3.  Long-term survival for 93 months of limited-stage small cell lung cancer: A case report and literature review.

Authors:  Yujie Zhong; Qiuhong Zhang; Wenjing Deng; Yuping Zhang; Zongjuan Ming; Yanli Hou; Zequn Niu; Shuanying Yang
Journal:  Thorac Cancer       Date:  2014-07-03       Impact factor: 3.500
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.